Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS (Details Narrative)

v3.23.1
DERIVATIVE FINANCIAL INSTRUMENTS (Details Narrative)
Sep. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
Oct. 30, 2020
USD ($)
$ / shares
shares
Feb. 28, 2020
$ / shares
shares
Jan. 06, 2020
USD ($)
$ / shares
shares
Jan. 02, 2020
$ / shares
shares
May 18, 2018
USD ($)
$ / shares
shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Derivative liability $ 741 $ 22,554          
Amended and Restated Loan Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants to acquire of common stock | shares             320,000
Warrant exercise price | $ / shares             $ 0.10
Derivative liability             $ 30,012
Warrant maturity date             May 11, 2021
Loan Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants to acquire of common stock | shares     5,000,000 200,000 5,000,000 5,000,000  
Warrant exercise price | (per share)     $ 0.05 $ 0.10 $ 0.10 $ 0.10  
Derivative liability         $ 144,259    
Warrant maturity date     Jan. 06, 2023 Mar. 01, 2022   Jan. 02, 2023  
Loan Agreement [Member] | Warrant [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Warrants to acquire of common stock | shares     5,000,000        
Warrant exercise price | $ / shares     $ 0.10        
Derivative liability     $ 95,352